References

Arvanitis LV, Mewaldt C, Krawisz A, Secemsky EA Approach to Resistant Hypertension: A Review of Recent Pharmacological Advances. Current Treatment Options in Cardiovascular Medicine. 2024; 27 https://doi.org/10.1007/s11936-024-01062-2

Bronstein D, Holman M, Wu R, Hayward J, Hani ZB, Paul C, Hawkins K Comparing antihypertensive strategies in hypertensive emergencies with heart failure. Am J Emerg Med. 2025; 88:192-196 https://doi.org/10.1016/j.ajem.2024.12.001

Elhiny R, O'Keeffe LM, Bodunde EO, Byrne S, Donovan M, Bermingham M Goal attainment, medication adherence and guideline adherence in the treatment of hypertension and dyslipidemia in Irish populations: A systematic review and meta-analysis. Int J Cardiol Cardiovasc Risk Prev. 2025; 24 https://doi.org/10.1016/j.ijcrp.2025.200364

Page MJ, McKenzie JE, Bossuyt PM The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372 https://doi.org/10.1136/bmj.n71

Prescribing for hypertension

02 April 2025
Volume 7 · Issue 4
blood pressure cuff

Abstract

Deborah Robertson provides an overview of recently published articles that may be of interest to non-medical prescribers. Should you wish to look at any of the papers in more detail, a full reference is provided

Last month, the research round-up provided you with an overview of three articles concerned with prescribing benzodiazepines. This month, we will review three articles around the management of hypertension. The first looks at recent medication advances in the management of resistant hypertension. The second article reviews treatment modalities in hypertensive heart failure. Finally, our third article deals with medication and guideline adherence in hypertension and hyperlipidaemia.

This article, published in the journal Current Treatment Options in Cardiovascular Medicine, sought to provide an update on the current clinical and pharmacological management of resistant hypertension. This review of recent and published research by the authors focuses on new and novel pharmacological therapies in the treatment of raised blood pressure (BP).

The review begins with an overview of resistant hypertension, and diagnosis of such, as well as investigation of possible secondary causes before discussing traditional management approaches. The follow-on to this is a review of new medications, which includes non-steroidal mineralocorticoid receptor antagonists, dual endothelin receptor antagonists, aldosterone synthase inhibitors, and angiotensinogen synthesis inhibitors.

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month